JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4151
PUT
Viking Therapeutics
VKTX
$3.76B
| $1.61M | ﹤0.01% |
40,000
-120,000
| -75% | -$6.84M |
2024 Q3
1 quarter
|
|
4152
Vanda Pharmaceuticals
VNDA
$280M
| $1.61M | ﹤0.01% |
335,741
+175,019
| +109% | +$840K |
2015 Q4
36 quarters
|
|
4153
Overlay Shares Large Cap Equity ETF
OVL
$461M
| $1.61M | ﹤0.01% |
34,472
-135,304
| -80% | -$6.4M |
2022 Q4
8 quarters
|
|
4154
Northeast Community Bancorp
NECB
$367M
| $1.61M | ﹤0.01% |
65,718
+45,403
| +223% | +$1.25M |
2023 Q1
7 quarters
|
|
4155
Nomad Foods
NOMD
$1.49B
| $1.61M | ﹤0.01% |
95,689
-11,068
| -10% | -$193K |
2017 Q2
30 quarters
|
|
4156
CALL
SoFi Technologies
SOFI
$20.4B
| $1.6M | ﹤0.01% |
104,000
+98,100
| +1,663% | +$1.27M |
2021 Q2
14 quarters
|
|
4157
Global X SuperDividend ETF
SDIV
$1.15B
| $1.6M | ﹤0.01% |
77,421
+11,401
| +17% | +$250K |
2019 Q4
20 quarters
|
|
4158
Stock Yards Bancorp
SYBT
$2.44B
| $1.59M | ﹤0.01% |
22,269
-148
| -0.7% | -$10.4K |
2013 Q2
46 quarters
|
|
4159
CALL
Royal Gold
RGLD
$19.9B
| $1.58M | ﹤0.01% |
12,000
-1,500
| -11% | -$216K |
2024 Q1
3 quarters
|
|
4160
Alerus Financial
ALRS
$814M
| $1.58M | ﹤0.01% |
82,194
+57,980
| +239% | +$1.27M |
2019 Q4
20 quarters
|
|
|
NYAX
4161
Nayax
NYAX
$1.83B
| $1.58M | ﹤0.01% |
+54,225
| New | +$1.49M |
2024 Q4
0 quarters
|
|
4162
ARK Blockchain & Fintech Innovation ETF
ARKF
$833M
| $1.58M | ﹤0.01% |
42,637
-2,756
| -6% | -$97.6K |
2020 Q4
16 quarters
|
|
4163
Harrow
HROW
$1.14B
| $1.57M | ﹤0.01% |
46,877
-191,490
| -80% | -$8.47M |
2019 Q3
21 quarters
|
|
|
XYZ
4164
PUT
Block Inc
XYZ
$44.7B
| $1.57M | ﹤0.01% |
18,500
-35,000
| -65% | -$2.87M |
2019 Q1
23 quarters
|
|
4165
CALL
CSX Corp
CSX
$87.9B
| $1.57M | ﹤0.01% |
48,600
| – | – |
2022 Q4
8 quarters
|
|
4166
NewAmsterdam Pharma
NAMS
$2.77B
| $1.57M | ﹤0.01% |
60,977
+38,626
| +173% | +$820K |
2024 Q1
3 quarters
|
|
4167
Preformed Line Products
PLPC
$2.05B
| $1.56M | ﹤0.01% |
12,238
+4,119
| +51% | +$535K |
2017 Q4
28 quarters
|
|
4168
DoubleLine Fortune 500 Equal Weight ETF
DFVE
$44.3M
| $1.56M | ﹤0.01% |
55,223
-4,777
| -8% | -$140K |
2024 Q1
3 quarters
|
|
4169
CALL
GlobalFoundries
GFS
$28B
| $1.56M | ﹤0.01% |
36,400
+35,700
| +5,100% | +$1.5M |
2024 Q3
1 quarter
|
|
4170
Schwab International Dividend Equity ETF
SCHY
$2.51B
| $1.56M | ﹤0.01% |
67,508
+16,580
| +33% | +$406K |
2023 Q4
4 quarters
|
|
4171
Distillate US Fundamental Stability & Value ETF
DSTL
$2.01B
| $1.56M | ﹤0.01% |
28,405
+4,818
| +20% | +$274K |
2023 Q2
6 quarters
|
|
4172
Grid Dynamics Holdings
GDYN
$651M
| $1.55M | ﹤0.01% |
69,845
-85,914
| -55% | -$1.5M |
2020 Q2
18 quarters
|
|
4173
iShares Global Consumer Discretionary ETF
RXI
$297M
| $1.55M | ﹤0.01% |
8,424
+2,775
| +49% | +$501K |
2018 Q1
27 quarters
|
|
4174
PUT
Talos Energy
TALO
$2.8B
| $1.55M | ﹤0.01% |
159,200
| – | – |
2024 Q2
2 quarters
|
|
|
SA
4175
Seabridge Gold
SA
$2.91B
| $1.54M | ﹤0.01% |
135,269
+111,084
| +459% | +$1.71M |
2018 Q3
25 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.